Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.

ABSTRACT:

SUBMITTER: Rodon P 

PROVIDER: S-EPMC4803137 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature